227 related articles for article (PubMed ID: 24840368)
21. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome.
Wilson S; Maddison T; Roberts L; Greenfield S; Singh S;
Aliment Pharmacol Ther; 2006 Sep; 24(5):769-80. PubMed ID: 16918880
[TBL] [Abstract][Full Text] [Related]
22. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
24. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review.
Rutten JM; Reitsma JB; Vlieger AM; Benninga MA
Arch Dis Child; 2013 Apr; 98(4):252-7. PubMed ID: 23220208
[TBL] [Abstract][Full Text] [Related]
25. The mind-body connection in irritable bowel syndrome: A randomised controlled trial of hypnotherapy as a treatment.
Phillips-Moore JS; Talley NJ; Jones MP
Health Psychol Open; 2015 Jan; 2(1):2055102914564583. PubMed ID: 28070348
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
Flik CE; Laan W; Zuithoff NPA; van Rood YR; Smout AJPM; Weusten BLAM; Whorwell PJ; de Wit NJ
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):20-31. PubMed ID: 30473202
[TBL] [Abstract][Full Text] [Related]
27. Hypnotherapy for smoking cessation.
Barnes J; McRobbie H; Dong CY; Walker N; Hartmann-Boyce J
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001008. PubMed ID: 31198991
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.
Samuthpongtorn C; Kantagowit P; Pittayanon R; Patcharatrakul T; Gonlachanvit S
Front Med (Lausanne); 2022; 9():1039284. PubMed ID: 36405622
[TBL] [Abstract][Full Text] [Related]
29. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M
Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463
[TBL] [Abstract][Full Text] [Related]
30. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
32. Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
Rutten JMTM; Vlieger AM; Frankenhuis C; George EK; Groeneweg M; Norbruis OF; Tjon A Ten W; van Wering HM; Dijkgraaf MGW; Merkus MP; Benninga MA
JAMA Pediatr; 2017 May; 171(5):470-477. PubMed ID: 28346581
[TBL] [Abstract][Full Text] [Related]
33. Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-analysis.
Goodoory VC; Khasawneh M; Thakur ER; Everitt HA; Gudleski GD; Lackner JM; Moss-Morris R; Simren M; Vasant DH; Moayyedi P; Black CJ; Ford AC
Gastroenterology; 2024 May; ():. PubMed ID: 38777133
[TBL] [Abstract][Full Text] [Related]
34. Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: A retrospective evaluation.
Peters SL; Gibson PR; Halmos EP
Neurogastroenterol Motil; 2023 Apr; 35(4):e14533. PubMed ID: 36661117
[TBL] [Abstract][Full Text] [Related]
35. Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS).
Lindfors P; Törnblom H; Sadik R; Björnsson ES; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2012 Dec; 47(12):1480-7. PubMed ID: 23094932
[TBL] [Abstract][Full Text] [Related]
36. Review article: the effectiveness of group and self-help hypnotherapy for irritable bowel syndrome and the implications for improving patients' choice and access to treatment.
Gillan C
Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1389-1404. PubMed ID: 34591988
[TBL] [Abstract][Full Text] [Related]
37. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Schumann D; Klose P; Lauche R; Dobos G; Langhorst J; Cramer H
Nutrition; 2018 Jan; 45():24-31. PubMed ID: 29129233
[TBL] [Abstract][Full Text] [Related]
38. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome.
Dionne J; Ford AC; Yuan Y; Chey WD; Lacy BE; Saito YA; Quigley EMM; Moayyedi P
Am J Gastroenterol; 2018 Sep; 113(9):1290-1300. PubMed ID: 30046155
[TBL] [Abstract][Full Text] [Related]
39. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
40. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.
Peters SL; Yao CK; Philpott H; Yelland GW; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2016 Sep; 44(5):447-59. PubMed ID: 27397586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
